First-line ribociclib plus letrozole in postmenopausal women with HR+ , HER2− advanced breast cancer: Tumor response and pain reduction in the phase 3 MONALEESA-2 trial

1. Janni, W.
2. Alba, E.
3. Bachelot, T.
4. Diab, S.
5. Gil-Gil, M.
6. Beck, T.J.
7. Ryvo, L.
8. Lopez, R.
9. Tsai, M.
10. Esteva, F.J.
11. Auñón, P.Z.
12. Kral, Z.
13. Ward, P.
14. Richards, P.
15. Pluard, T.J.
16. Sutradhar, S.
17. Miller, M.
18. Campone, M.